Donate

Blog

T1International Publishes Survey on Type 1 Diabetes, COVID, and Insulin Rationing

T1International Publishes Survey on Type 1 Diabetes, COVID, and Insulin Rationing

In September 2021, T1International’s latest out-of-pocket cost survey was published in the Journal of Diabetes Research and Clinical Practice. Conducted every two years, this study is the most comprehensive patient-led out-of-pocket cost survey for people living with type 1 diabetes. Read more

T1International Advocates Win: WHO Adds Long-Acting Insulin Analogues to EML

T1International Advocates Win: WHO Adds Long-Acting Insulin Analogues to EML

T1International’s global community of people living with and affected by diabetes and their allies celebrates a monumental advocacy win as the World Health Organization announced the addition of long-acting insulin analogues to the Model List of Essential medicines (EML). Read more

T1International Hosts 3rd Annual #insulin4all Workshop

T1International Hosts 3rd Annual #insulin4all Workshop

Join us for T1International’s annual #insulin4all Workshop: Advocate, Don’t Celebrate. This event is an opportunity for advocates from around the world to learn from each other, build community, and take action in the fight for #insulin4all. Read more

Global Advocacy Success Series: Cyrine, Lebanon

Global Advocacy Success Series: Cyrine, Lebanon

T1International has provided tools and support to ensure Cyrine’s plans are detailed and realistic, and allowed her to connect with other advocates around the world who can offer support and guidance. Read more

Redirecting Guilt into Action

Redirecting Guilt into Action

It’s crucial that those of us who have access to insulin use our platform and privilege to fight for our community and for the people with diabetes who are solely focused on surviving. We must serve as the voice for the people with diabetes who can’t use their own because they’re bogged down working three jobs and choosing between putting food on the table for their family or insulin. Read more

T1International Comment on Application to Add Long-acting Insulin Analogues to the WHO EML

T1International Comment on Application to Add Long-acting Insulin Analogues to the WHO EML

The WHO justifying inaction by saying it will not be adequate fails to address the issue of manufacturer monopolies and price-gouging. To see a world health leader taking this stance is extremely disheartening. Not to mention, civil society groups, including T1International, have coordinated actions to address the root causes of the issue. If the application is rejected for a third time, the diabetes community will continue to feel that the voices of people with diabetes do not matter and that the WHO is not listening to those who live this reality every day. Read more

Underrepresented Communities and Navigating the System

Underrepresented Communities and Navigating the System

Seven years after my diagnosis my brother was also diagnosed with type 1 diabetes which made the already bad financial burden worse. Although all people with diabetes struggle with how expensive diabetes can be, immigrants and people of color often do not have access to quality health insurance (or any access) so they are less likely to benefit from advanced diabetes technology. As I got older I began to understand how difficult it is to navigate a system that makes it harder for people in underrepresented communities to get adequate care. Read more

From Patient to Medical Student: My Journey with Diabetes Treatment

From Patient to Medical Student: My Journey with Diabetes Treatment

Having lived with type 1 diabetes for more than 12 years, I have experienced different aspects of the condition. First of all, as a patient, I approach diabetes from a personal view. I can also understand how the condition affects parents of children with diabetes. It's something new, demanding and difficult to handle. The last five years, as a medical student in Greece, I have seen diabetes from yet another more practical and scientific perspective. Read more

T1International Statement Endorsing H.R.3

T1International Statement Endorsing H.R.3

For years, T1International and our advocates have been calling on both state and federal legislators to take action to address exorbitant drug prices. American lives depend on real action. That’s why T1International USA endorses the Elijah E. Cummings Lower Drug Costs Now Act (H.R.3). Read more

T1International Launches 100 Years: From Gift to Greed Campaign

T1International Launches 100 Years: From Gift to Greed Campaign

On Monday, May 17th - 100 years after Banting, Best and Macleod begin their first experiment trying to extract insulin in Toronto - T1International and its advocates around the world launch their year-long campaign. 100 Years: From Gift to Greed will tell the story of insulin’s discovery and how it went from being a gift to the world to a profit machine for the pharmaceutical industry. The campaign will be led by a combination of social media education and a variety of actions. Read more